Infusion Nursing Notes by Nufactor provides education, resources and support to promote successful patient therapy within the infusion nursing community.

Tips and FAQs About Ordering and Organizing Infusion Supplies

Discover best practices to keep you and your patient prepared and organized for infusion day. The most important thing you will need in the home as a field nurse are proper supplies. If anything is missing, it may delay the infusion or cause it to be rescheduled. Nufactor provides all ancillary supplies a nurse needs to complete an infusion except for a stethoscope, blood pressure cuff, and thermometer, which are to be provided by the nurse. Upon start of care (SOC), the pharmacy will send a small quantity of extra supplies in a labeled back up kit. This helps to ensure the infusion can be completed if extra supplies are needed unexpectedly. The back up kit also contains items that may only be needed in specific situations such as rate flow tubing or N95 masks. If ordered, an anaphylaxis kit is also provided at SOC. [More]

Practical Strategies for Patients and Caregivers to Minimize Reactions with Subcutaneous Immune Globulin (SCIG)

Providing clear and concise information for patients receiving subcutaneous immune globulin (SCIG) therapy, is of utmost importance. SCIG treatments can be life-changing for people with immune deficiencies and autoimmune conditions; localized site reactions are anticipated and generally well-tolerated and should not be considered a contraindication to treatment continuation. In this blog, I will share some practical strategies to help minimize these reactions and hopefully improve the overall experience for patients and caregivers. Typical localized site reactions include but are not limited to burning, itching, redness, swelling, and pain to injection sites. These reactions should minimize over time once the body gets used to the drug. [More]

HYQVIA® 10% — Learn About Expanded FDA-Approval for Treating PIDD and CIDP

HYQVIA® [Immune Globulin Infusion 10% (Human) with Recombinant Human Hyaluronidase] Solution, for subcutaneous administration was first FDA-approved in 2014 for primary immunodeficiency (PIDD) in adults. In 2023, HYQVIA® received expanded FDA-approval in PIDD to include pediatric patients aged 2-16. In 2024 HYQVIA® received FDA-approval for maintenance therapy in adults with chronic inflammatory demyelinating polyneuropathy (CIDP). [More]

Mastering IV Access at Home: Best Practices for Safe Infusion Therapy

Home infusion therapy requires a high level of knowledge and proficiency in intravenous (IV) skills, including the insertion, management, and monitoring of peripheral IV lines , as well as expertise in central line accessing and management. Strong competency in both peripheral and central access devices is imperative in ensuring patient safety and optimal outcomes. [More]

Understanding Crohn's Disease: Symptoms, Diagnosis, and Treatment Options

Crohn's disease is a chronic inflammatory bowel disease (IBD) characterized by inflammation of the gastrointestinal (GI) tract. Crohn’s disease can affect any part of the digestive tract. Symptoms can include frequent, recurring diarrhea, rectal bleeding, fever, reduced appetite, unexplained weight loss, fatigue, abdominal pain, abdominal cramping, mouth sores and pain or drainage near or around the anus due to inflammation from a tunnel into the skin (fistula). [More]

SCIG and Blood Return

With Hizentra® 10 gm/50 mL prefilled syringes now commercially available, we have learned of some patients accidentally pulling out the syringe plunger when checking for blood return before administration. This may be related to the design and need for better dexterity and has resulted in wasted medication and delayed doses. [More]